Manhattan Associates (NASDAQ:MANH – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday.
A number of other equities research analysts have also issued reports on MANH. Barclays dropped their price objective on shares of Manhattan Associates from $239.00 to $201.00 and set an “overweight” rating for the company in a report on Friday, May 29th. DA Davidson reiterated a “buy” rating and issued a $200.00 target price on shares of Manhattan Associates in a report on Wednesday, May 20th. Stifel Nicolaus set a $200.00 target price on shares of Manhattan Associates in a report on Wednesday, May 20th. Rothschild & Co Redburn set a $145.00 price target on shares of Manhattan Associates in a research note on Thursday, April 16th. Finally, Robert W. Baird raised their price target on shares of Manhattan Associates from $183.00 to $186.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Eight analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $199.45.
Read Our Latest Research Report on MANH
Manhattan Associates Stock Performance
Manhattan Associates (NASDAQ:MANH – Get Free Report) last issued its earnings results on Tuesday, April 21st. The software maker reported $1.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.14. Manhattan Associates had a return on equity of 78.13% and a net margin of 19.68%.The business had revenue of $282.21 million during the quarter, compared to the consensus estimate of $273.70 million. During the same period last year, the company earned $1.19 EPS. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. Manhattan Associates has set its FY 2026 guidance at 5.290-5.370 EPS. As a group, sell-side analysts forecast that Manhattan Associates will post 3.68 EPS for the current year.
Manhattan Associates announced that its Board of Directors has initiated a stock repurchase plan on Thursday, March 5th that authorizes the company to repurchase $500.00 million in outstanding shares. This repurchase authorization authorizes the software maker to purchase up to 5.8% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s management believes its shares are undervalued.
Insider Transactions at Manhattan Associates
In other Manhattan Associates news, EVP James Stewart Gantt sold 7,300 shares of the company’s stock in a transaction dated Friday, April 24th. The shares were sold at an average price of $139.25, for a total value of $1,016,525.00. Following the transaction, the executive vice president owned 60,815 shares of the company’s stock, valued at $8,468,488.75. This represents a 10.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Eric Andrew Clark sold 1,000 shares of the stock in a transaction dated Wednesday, June 10th. The stock was sold at an average price of $146.77, for a total transaction of $146,770.00. Following the transaction, the chief executive officer directly owned 92,638 shares of the company’s stock, valued at approximately $13,596,479.26. This trade represents a 1.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.84% of the company’s stock.
Hedge Funds Weigh In On Manhattan Associates
A number of hedge funds have recently made changes to their positions in the stock. Eagle Bay Advisors LLC acquired a new stake in Manhattan Associates in the 4th quarter valued at approximately $27,000. Caitong International Asset Management Co. Ltd boosted its position in shares of Manhattan Associates by 448.0% during the third quarter. Caitong International Asset Management Co. Ltd now owns 137 shares of the software maker’s stock worth $28,000 after buying an additional 112 shares during the period. BNP Paribas purchased a new position in shares of Manhattan Associates during the fourth quarter worth $39,000. TD Private Client Wealth LLC grew its stake in shares of Manhattan Associates by 83.8% in the fourth quarter. TD Private Client Wealth LLC now owns 239 shares of the software maker’s stock valued at $41,000 after buying an additional 109 shares in the last quarter. Finally, V Square Quantitative Management LLC acquired a new stake in shares of Manhattan Associates in the fourth quarter valued at $44,000. Hedge funds and other institutional investors own 98.45% of the company’s stock.
About Manhattan Associates
Manhattan Associates, Inc (NASDAQ: MANH) is a provider of supply chain and omnichannel commerce software solutions designed to optimize the flow of goods, information and funds across enterprise operations. Its flagship offerings include warehouse management, transportation management, order management and omnichannel fulfillment applications. These solutions are delivered through a cloud-native platform called Manhattan Active, which enables retailers, manufacturers, carriers and third-party logistics providers to orchestrate inventory, manage distribution and improve customer service in real time.
Key product areas include Manhattan Active Warehouse Management, which automates and optimizes warehouse operations from receiving through shipping; Manhattan Active Transportation Management, supporting carrier selection, routing and freight payment; and Manhattan Active Omni, which unifies order capture, inventory visibility and fulfillment across stores, distribution centers and e-commerce channels.
Recommended Stories
- Five stocks we like better than Manhattan Associates
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for Manhattan Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Manhattan Associates and related companies with MarketBeat.com's FREE daily email newsletter.
